The Healthcare and Economic Impact of Drug Shortages


The Healthcare and Economic Impact of Drug Shortages
Monday, February 14, 2011
2 p.m. EST, 11 a.m. PST

Click here to register.

Drug shortages have been occurring with increasing frequency in recent years, with adverse consequences including medical complications and higher prices.

In this webinar, we will discuss the forthcoming study by NERA Economic Consulting in which case studies in drug supply disruptions show that sharp reductions in production by one or more manufacturers often coincided with an increase in supply by other manufacturers. Nevertheless, the shifts in the production were usually associated with sharp price increases, which can be more pronounced for independent pharmacies.

If the number of shortages continues to increase over time, some evidence indicates that the strength and scale of large buyer groups, particularly those managed by large wholesalers, may provide independent pharmacies some protection from the effects of shortages, including sharper relative price increases.
When: Monday, February 14, 2011, 2 p.m. EST, 11 a.m. PST

Graeme Hunter, Vice President, NERA Economic
John Calabrese, Senior Director, Sales and National Accounts, Greenstone LLC

Click here to register.

Please note: This webinar is for information purposes only; attendance will not contribute to CE credits.

FacebookTwitterGoogle+WordPressBookmark/FavoritesBlogger PostShare